Home › Funds › Caption Management, LLC › GSK

Caption Management, LLC position in GSK

GSK PLC ADR F · Health Care

Caption Management, LLC reported holding 658,000 shares of GSK (GSK PLC ADR F) in its Q2 2026 13F filing — a position valued at US$34.5M, representing 0.59% of its reported portfolio and ranking #36 among its reported holdings. Caption Management, LLC has disclosed GSK holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)658.00K sh
Reported value held$34.49M
Portfolio Weight0.59%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caption Management, LLC's GSK position evolved

Caption Management, LLC first disclosed a stake in GSK in Q3 2023 at 5,000 shares (US$181K). The position peaked in Q2 2026 at 658,000 shares, worth US$34.5M. Across 5 filings, Caption Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 658,000 shares valued at US$34.5M. Notable position changes include a 650% increase in Q3 2024 (shares fell 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.00K $181.25K New
Q4 2023 5.00K $185.30K Hold
Q2 2024 20.00K $770.00K New
Q3 2024 150.00K $6.13M Add
Q2 2026 658.00K $34.49M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has Caption Management, LLC held GSK?

Caption Management, LLC has disclosed GSK holdings in 5 of the last 12 reported quarters, going back to Q3 2023.

What is Caption Management, LLC's current position in GSK?

As of Q2 2026, Caption Management, LLC holds 658.00K shares of GSK (GSK PLC ADR F), valued at $34.49M, representing 0.59% of its reported portfolio and ranking #36.

Has Caption Management, LLC been buying or selling GSK?

In the latest 13F filing (Q2 2026), Caption Management, LLC newly opened its position in GSK. The position peaked in Q2 2026 at 658.00K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.